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Abstract
Objective: This prospective observational study was designed to evaluate the point prevalence as well as various risk factors associated 
with retinopathy of prematurity (ROP) in preterm/low birth weight (LBW) babies <32 weeks of gestation and or birth weight ≤1500 g on 
both inborn and outborn babies. Materials and Methods: Binocular opthalmological examination was performed 4-6 weeks postnataly 
under local eye anesthesia in 200 newborns who qualified the above criteria. If ROP was detected, the 2nd evaluation was done after 
1 week, 3rd evaluation after 2 weeks and 4th after 4 weeks. The examination was carried out by the same ophthalmologist. Results: 
25 (12.5%) out of 200 babies developed ROP. 23 were in Stage 1 and 2 in Stage 2 at first evaluation. All showed regression, i.e., they 
had completed temporal vascularization on repeat follow-up evaluations. No baby showed progression to threshold stage at any time of 
follow-up examinations. On multiple logistic regression analysis, factors having significant association with development of ROP were 
birth weight (p = 0.0028), oxygen therapy (p = 0.0059), septicemia (p = 0.0062), and blood transfusion (p = 0.0013). Conclusion: In 
our study, point prevalence of ROP was 12.5 % (25/200) which is substantially high among preterm/LBW babies. Thus, evaluation for 
ROP should be done mandatorily in all preterm/LBW babies, particularly with gestation <32 weeks and or weight ≤1500 g and when 
risk factors are present, so as to prevent the long-term morbidity which ranges from mild myopia to blindness.
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Retinopathy of prematurity (ROP) is a multifactorial vasoproliferative retinal disorder that increases in the incidence with decreasing gestational age/birth weight 
and duration of ventilation [1-3]. ROP is the main cause of visual 
impairment in premature infants [4]. Advances in neonatology 
and improvements in the quality care have resulted in increasing 
number of premature and extremely low birth weight (ELBW) 
babies surviving the neonatal period leading to an increase in the 
population at risk for developing ROP [5,6]. 90% of infants with 
birth weight <750 g and 47% between 1000 and 1250 g develop 
ROP. Approximately, 80% of infants born at <28 weeks versus 
30% born after 28 weeks are at risk for developing ROP [7].
Other factors implicated in the pathogenesis include 
vitamin E deficiency, multiple red blood transfusions, intra-
ventricular hemorrhage, bronchopulmonary dysplasia, oxygen 
exposure, fluctuations in blood gas tensions, and sepsis [3]. In 
the majority of the infants, ROP is a mild disease and undergoes 
spontaneous regression with no significant visual sequelae. 
However, in a significant number of cases progression to 
advanced ROP occurs resulting in severe visual impairment. 
Long-term morbidity of ROP has a spectrum ranging from mild 
myopia to blindness. It therefore, continues to be important 
cause of childhood blindness [2].
Ours is a tertiary care teaching hospital, where many 
high-risk deliveries are conducted every day of which a large 
number are pre-terms/LBW babies and almost equal number 
of out born preterm/LBW babies are admitted daily being a 
referral hospital. Due to advances made in the neonatal care 
at our center (level III neonatal intensive care unit [NICU] 
without ventilators) and better survival in our center, there may 
be increasing number of preterm/LBW babies who are at risk 
of developing ROP. Previously no such study had been done 
in our hospital/state, thus this study was designed to evaluate 
incidence as well as various risk factors associated with ROP in 
preterm infant ≤1500 g and or <32 weeks of gestation.
MATERIALS AND METHODS
The present prospective observational study was conducted in 
the Postgraduate Department of Pediatrics and Ophthalmology 
of a Tertiary Care Teaching Hospital from north India over 
a period of 1 year from September 2008 to August 2009. 
Institutional Ethics Committee approval was obtained before 
starting the study. Preterm/LBW babies who were admitted in 
NICU, both inborn and outborn babies were recruited in the 
study after taking written consent from the parents.
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All preterm/LBW with gestational age <32 weeks and/or 
birth weight ≤1500 g were included in the study. Gestational age 
was calculated according to new Ballard scoring system [8], 
last menstrual period, and antenatal ultrasonography. 
Investigations like sepsis screen, arterial blood gas analysis, 
echocardiography or any other investigations were done as and 
when required.
Following definitions were used for the study purposes [9].
Preterm baby: Baby with gestation of <37 completed weeks.
LBW baby: Baby with birth weight <2500 g (up to and 
including 2499 g), irrespective of the period of gestation.
Very LBW baby: Baby with weight <1500 g (up to and 
including 1499 g).
ELBW: Baby with birth weight <1000 g (up to and including 
999 g).
Hypothermia: Hypothermia in a newborn baby was defined 
as skin temperature of 35.5°C or less or core temperature of 
36.0°C or less.
Fever: Fever was defined as core temperature of 38.0°C or 
more or skin temperature 37.5°C or more.
Sepsis: Sepsis was diagnosed clinically and supported by 
changes in leukocyte count (leukocyte count >20000/mm3 or 
<5000/mm3 or absolute neutropenia <1000/mm3), the band cell 
count of >20% and band count to total neutrophil ratio of ≥0.2, 
C-reactive protein >8 mcg/ml and/or positive blood culture.
Birth asphyxia: Birth asphyxia was defined as gasping or no 
breathing at 1 min or Apgar score <4 at 1-min.
All the recruited babies were subjected to indirect binocular 
opthalmological examination between 4 and 6 weeks of 
postnatal age as recommended by the American Academy 
of Opthalmology for detection of retinopathy [10]. Pupillary 
dilatation was achieved by instillation of eyes drops containing 
tropicamide 0.5 % and phenylephrine 2% one drop every 10 min 
for 3 times 1 h prior to the examination. The examination was 
done under local anesthetic drops put into the eyes and using 
eyelid speculum after restraining the baby in the mother’s lap.
If no ROP was detected in the initial examination, the 
infants were re-evaluated once every 2 weeks until they were 
discharged from the hospital. There after they were examined 
every 4 weeks until vascularization was complete. If ROP 
was detected, the 2nd re-evaluation was done after 1 week, 
3nd after 2 weeks and 4th after 4 weeks for stage 1 and 2 and 
more frequently for stage 3 disease, till the disease started 
resolving or showed progression to the threshold stage. Babies 
showing evidence of regression were followed weekly till 
vascularization was complete. Because the procedure could be 
stressful, the babies examined were clinically stable at the time 
of examination. Parents were informed about the diagnosis 
when it was first made and given subsequent date with 
follow-up examination. All ophthalmological examinations 
were performed by the same ophthalmologist with no prior 
knowledge of the patient’s medical history. Staging of ROP 
was done according to the International Classification of 
ROP [3,11,12].
Statistical Analysis
The data were analyzed with the help of SPSS Statistics for 
Windows, Version 12.0 (SPSS Inc., Chicago, USA). Qualitative 
variables reported as percentages, mean and standard deviation. 
Univariate analysis was conducted to assess the relationship of 
various variable with the outcome i.e., ROP. Chi-square test/
Chi-square for time trend was applied to develop statistical 
significance. The strength of association was reported as odd’s 
ratio (OR) with its 95% confidence interval (CI). Multivariate 
analysis was implied to assess the independent effect of each 
variable in the development of ROP. The value of <0.05 was 
considered as statistically significant.
RESULTS
During the study period, 200 preterm/LBW babies with 
gestational age <32 weeks and/or birth weight of ≤1500 g were 
screened for development of ROP. 75% (3/4), 70% (14/20), 
and 3.4% (8/176) of newborn with birth weight up to 1000 g, 
1001-1250 g and 1251-1500 g developed ROP, respectively. 
The overall risk of development of ROP in neonates with birth 
weight up to 1000 g was observed to be 63 (OR) with 95% CI 
of 4.86-1779 and in newborn with weight between 1001 and 
1250 g, the overall risk was 49 with 95% CI (13.09-196.84). The 
observation was statistically highly significant (p < 0.00001). 
Same was the relationship of gestational age with ROP as of 
birth weight (Table 1). As regards sex the risk of development 
of ROP in male neonate was observed to be 1.50 (OR) with 95% 
CI (0.58-3.90). However, this observation is not statistically 
significant (p < 0.48).
Of 56 newborns who received oxygen therapy, 30.3% 
(17/56) developed ROP as compared to 4.8% (8/144) of 
newborn who did not. The oxygen therapy was given from 
centralized oxygen source, through headbox for duration from 
1 h to 50 h (mean 6 h) at an ambient concentration raised to 
40% or more depending upon the need. The aim was either 
relief of cyanosis or maintenance of arterial po2 between 
50 and 80 mm Hg. No baby was put on continuous positive 
airway pressure or ventilator. The overall risk of development 
of ROP in newborn receiving oxygen therapy was 7.41 (OR) 
with 95% CI (2.75-20.44). This observation was statistically 
highly significant (p < 0.000).
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The overall risk of ROP in babies having anemia was 12.96 
(OR) with 95% CI (4.22-40.62) and 52.3% (11/21) of babies 
with anemia developed ROP against 7.8% (14/179) without 
anemia (p < 0.0001). Similarly, 52.3% (11/21) of babies 
who received blood transfusion developed ROP as compared 
to 7.8% (14/179) of babies who did not (OR: 12.96, 95% 
CI: 4.22-40.62).
About 45% (9/20) of babies who received phototherapy 
developed ROP as compared to 8.8% (1/180) of babies who 
did not receive phototherapy. The overall risk of ROP in these 
babies was 8.39 (OR) with 95% CI 2.70-26.18, (p < 0.0000). 
Similar trend in babies receiving exchange transfusion and 
53.8% (7/13) of babies who underwent exchange transfusion 
developed ROP compared to 9.6% (18/187) who did not (OR: 
10.95, 95% CI: 2.90-42.31, p < 0.0000).
Blood culture was positive in 30 babies out of 50 babies 
with sepsis. The overall risk of development of ROP in babies 
who had septicemia was 11.49 (OR) with 95% CI of 4.09-33.44. 
36% (18/50) of babies who had septicemia developed ROP 
as compared to 4.6% babies (7/150) without septicemia 
(p < 0.0000). 31.3% (14/43) of babies with birth asphyxia 
developed ROP as compared to 7% (11/157) of non-asphyxiated 
babies (OR: 6.41, 95% CI: 2.44 -17.02, p < 0.0002). The overall 
risk of ROP in babies with congenital heart disease was 24.05 
(OR) (95% CI: 5.85-106.83, p < 0.0000). As regards the relation 
of mode of delivery, the overall risk of ROP in newborns 
delivered per vaginally was 1.20 (OR) (95% CI: 1.45-3.09, 
p < 0.68). The risk of ROP in hospital born preterm versus home 
born was 1.48 (OR) with 95% CI: 1.59-3.78 (p < 0.36).
On multiple logistic regression analysis, factors having 
statistically significant association with development of ROP 
were birth weight (p = 0.0028), oxygen therapy (p = 0.0059), 
septicemia (p = 0.0062), and blood transfusion (p = 0.0013) as 
shown in Table 2.
Of 200 babies, 25 (12.5%) developed ROP and out of these 
25 babies, 23 (92%) were in Stage 1 and 2 (8%) were in stage 
2. After 2nd evaluation after 1 week, 16 (64%) were in Stage 1 
and 2 (8%) were still in Stage 2, while in 3rd evaluation after 
2 weeks only 9 (36%) were in Stage 1 and none of them was in 
Stage 2. After 4th evaluation done after 4 weeks, all the babies 
showed spontaneous resolution and none of the baby was in 
any stage of ROP (Table 3). No baby showed progression to 
threshold stage at any time of follow-up examination and all 
had completed temporal vascularization.
DISCUSSION
The point prevalence of ROP was 12.5% in this study. Various 
studies have reported higher incidence of ROP varying from 
18% to 32.4% as shown in Table 4. The low incidence of ROP 
in the present study could p ossibly be due to non-availability of 
ventilatory support as not much of preterm/very ELBW babies 
survived till 4-6 weeks of post-conceptional age when first 
ROP examination was done. Previous studies have shown the 
association of duration of ventilation with increasing incidence 
of ROP besides decreasing gestational age/LBW [1,3]. In our 
study, birth weight, oxygen therapy, septicemia, and blood 
transfusion were the independent factors found to be associated 
with the development of ROP.
LBW and prematurity have been well-documented 
to be associated with the development of ROP in many 
studies [12-15]. In this study, birth weight of 1000 g and 
between 1001-1500 g had a significant association with risk 
of development of ROP (OR: 63; 95% CI: 4.86-17.79 and OR: 
49; 95% CI: 13.09-196.84, respectively). These observations 
are comparable with the observations of Hussain et al. [6] 
and Bonotto et al. [16], who also observed significantly high 
risk of development of ROP in LBW babies. Similar are our 
observations, as regards gestational age and babies with 
gestational age of up to 28 weeks and those between 29 and 
30 weeks had a higher chances of development of ROP (OR 
63; 95% CI 4.86-17.79 and OR 49; 95% CI 13.09-196.84 
respectively). Gupta et al. [15] also found that lower gestational 
significantly increased the incidence of ROP. In our study, 
gender had no significant association with ROP (p < 0.48) as 
seen by Gupta et al. [15] and Shah et al. [17].
Kinsey and Zacharias [18], Prendiville and Schulenburg [1] 
found significant association between oxygen therapy and 
ROP. In our study also, highly significant association (p<0.000) 
was seen between two as 30.3% preterm who were exposed to 
oxygen therapy developed ROP as compared to 4.8% who were 
not. Al-Essa et al. [19] found high concentration of oxygen 
therapy (OR 94; 95% CI 0.91-0.97; p = 0.0001) independently 
associated with the risk of development of ROP.
Table 1: Relation of weight and gestational age with ROP
Weight (g)/gestational 
age (weeks)
No. (%) Crude OR (95% CI)
ROP 
(n=25)
No ROP 
(n=175)
Up to 1000/28 (n=4) 3 (75) 1 (25) 63 4.86-1779
1001-1250/29-30 (n=20) 14 (70) 6 (30) 49 13.09-196.84
1251-1500/31-32 (n=176) 8 (3.4) 168 (97.7) (reference)
χ2 for time trend=77.2, p<0.0000, OR: Odd’s ratio, CI: Confidence interval, ROP: Retinopathy of prematurity
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In this study, association between ROP and phototherapy 
was highly significant (p < 0.0000). Nair et al. [14] also found 
phototherapy as a risk factor for development of ROP. Yeo 
et al. [20] reported that phototherapy by reducing bilirubin 
which is an endogenous antioxidant may promote free radical 
mediated injury and thus increase risk of diseases such as ROP. 
Exchange transfusion was also observed to be associated with 
ROP (p < 0.0000) as reported by other researchers also [21-23].
We found that blood transfusion was an independent risk 
factor for the development of ROP (OR: 12.96; 95% CI: 
4.22-40.62). Previously conducted studies by Nair et al. [14], 
Ballard et al. [8], and Bonotto et al. [16] also showed similar 
association. It has been shown that adult hemoglobin, being 
more capable of releasing oxygen to tissues, causes tissue level 
hyperoxia and thus leads to development of ROP [24-26]. In 
the present study, 52.3% of anemic preterm developed ROP 
as compared to 7.8% without anemia (p<0.0001). Swarna 
and Battu [12] and Dutta et al. [23] also found anemia as a 
significant risk factor for development of ROP.
In our study, 36% of preterm babies with septicemia developed 
ROP as compared to 4.6% without septicemia (p < 0.0000). 
Various studies also found septicemia as independent risk factor 
for ROP [12,14,15,20,21,27]. It has been observed that sepsis 
may act through cytokines and endotoxins or by oxidative 
burst in the neutrophils consequent to infection leading to 
ROP [15,21]. We found significant association between history 
of delayed cry/hypoxic ischemic encephalopathy as a risk factor 
for ROP was (p < 0.0002). Shah et al. also showed that infants 
with threshold ROP had lower 1 min Apgar score as compared 
to infants without ROP [17]. We also found association between 
history of congenital heart disease requiring ionotropes and 
development of ROP which is in collaboration with results of 
studies conducted by Nair et al. [14] and Yang et al. [28].
In our study, 25 babies developed ROP at first evaluation out 
of 200 babies screened. Of these 25 babies, 23 (92%) were in 
Stage 1 ROP and 2 (8%) in Stage 2. After repeated evaluations 
done after 1, 2, and 4 weeks, all of these showed evidence of 
regression i.e., they had completed temporal vascularization. 
No baby showed progression to threshold stage at any time of 
follow-up examination.
Few limitations of our study include small sample size, 
short follow-up period, and less number of high risk babies 
due to less ELBW babies and inclusion of only nonventilated 
babies due to non-availability of the ventilator in our setup.
CONCLUSION
Retinopathy is substantially high among preterm/LBW babies. 
Therefore, all preterm/LBW babies, particularly neonates with 
Table 2: Results of multiple logistic regression analysis in ROP
Variable β SE Significance R Inference
Gestational age −0.0388 0.3990 0.9226 0.0000 NS
Birth weight −13.5861 4.5481 0.0028 −0.4330 S
Oxygen 3.8578 1.4008 0.0059 0.3889 S
Septicemia 4.0296 1.4711 0.0062 0.3860 S
Phototherapy 3.0856 1.7919 0.0851 0.1617 NS
Blood transfusion 4.6394 1.4380 0.0013 0.4771 S
Exchange transfusion 1.9272 1.4513 0.1842 0.0000 NS
Gender 1.5545 1.851 0.1896 0.0000 NS
Constant 12.2999 9.5926 0.1998 - NS
S: Significant, NS: Non significant, ROP: Retinopathy of prematurity
Table 3: Stage of ROP in 25 babies at first screening and 
subsequent follow-up
Timing of 
examination 
(in weeks)
Stage 1 Stage 2 Stage 3 Stage 4
1st evaluation 
(4-6 weeks of 
PCA)
23 (92) 2 (8) - -
2nd evaluation 
(after 1 week)
16 2 - -
3rd evaluation 
(after 2 week)
9 0 - -
4th evaluation 
(after 4 week)
0 0 - -
Figures in parenthesis are percentages, ROP: Retinopathy 
of prematurity
Table 4: Incidence of ROP reported in various studies
Study group Year Incidence (%)
Darwan et al. [29] 1996 21
Patil et al. [13] 1997 18
Varughese et al. [30] 2001 21
Yang et al. [28] 2001 25
Nair et al. [14] 2003 25.4
Gupta et al. [15] 2004 21
Taqui et al. [18] 2008 32.4
Present study 2009 12.5
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gestation <32 weeks and/or weight ≤1500 g and when risk factors 
are present, should be screened for ROP so that timely treatment 
can be instituted in babies who have progressed to threshold 
stage disease so as to prevent long-term morbidity of ROP.
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